In the mouse Tabby (Ta) mutant and human X-linked anhidrotic ectodermal dysplasia (EDA) syndrome development of several ectodermal organs such as hair, teeth, and sweat glands is impaired. The gene behind Tabby and EDA has been cloned, and several alternative transcripts have been isolated. The protein product named ectodysplasin had no obvious function or prominent homology to other known gene products apart from a short collagen-like sequence. We have isolated two novel Ta transcripts which are variants of the longest isoform of Tabby, named Ta-A. In situ hybridizations revealed Ta-A to be the major transcript in the developing embryo. It was detected in the endoderm of early embryos and subsequently in speci®c locations in the neuroepithelium and ectoderm. Unexpectedly, sequence analysis of the most C-terminal domain of Ta revealed that ectodysplasin is a novel member of the tumor necrosis factor (TNF) ligand superfamily. Mouse ectodysplasin was biochemically and functionally characterized, and shown to be a glycosylated, oligomeric type II membrane protein (N-terminus inside), all characteristics typical to TNF-like proteins. Members of the TNF family are critically involved in host defence and immune response often mediating either apoptosis or cell survival. Expression of Ta in several epithelial cell lines did not result in prominent changes in cell morphology and did not promote apoptosis. Instead, it was shown to promote cell adhesion to extracellular matrix, a function consistent with its postulated role in epithelial-mesenchymal interactions regulating the development of ectodermal appendages. Ectodysplasin is the ®rst TNF-like signaling molecule described known to be required for epithelial morphogenesis. q
Introduction
The morphogenesis of all organs is regulated by a sequence of inductive interactions between epithelial and mesenchymal cells. At the molecular lever, these interactions are mediated by complex signaling networks that consist of signaling molecules, their receptors and downstream effector molecules. The most studied signal protein families include bone morphogenetic proteins (BMPs), ®broblast growth factors (FGFs), hedgehog family, and wnt family. In addition, a number of other signal families such as PDGF, HGF, EGF, and IGF have important roles in mediating cell interactions in morphogenesis. Besides soluble signaling molecules, interactions between cells and between cells and extracellular matrix (ECM) are involved in the regulation of epithelial morphogenesis during embryonic organ development, and increasing evidence indicates that the pathways from soluble ligands and ECM receptors converge intracellularly (Gumbiner, 1996) .
The Tabby (Ta) mouse and human X-linked anhidrotic (hypohidrotic) ectodermal dysplasia (EDA) are characterized by abnormal development of several ectodermally derived organs such as teeth, hair, and a number of exocrine glands including sweat glands and salivary glands (Slavkin et al., 1998; OMIM) . Two other mouse strains, downless and crinkled, share identical phenotypes with Ta (Slavkin et al., 1998) . Downless and crinkled have autosomal locations whereas the synthetically equivalent positions of Ta and EDA genes on X chromosome suggested their identity. The gene coding for EDA was ®rst identi®ed by positional cloning (Kere et al., 1996) , and the subsequent cloning of Tabby con®rmed it to be the mouse homologue of EDA and the protein was named ectodysplasin Ferguson et al., 1997) . Originally, an EDA cDNA of 858 bp coding for a 135 amino acid protein (EDA-O) was described. The predicted translation product had no obvious function or apparent homology to other known proteins apart from a brief collagen-like repeat (Gly-X-Y) 4 (Kere et al., 1996) . The polypeptide did not have a signal sequence but was predicted to contain a single transmembrane domain suggesting that it is an integral membrane protein, which has later been con®rmed . Recently, several alternative transcripts have been identi®ed both in mouse and human Baye Âs et al., 1998) . Exon 1 and thus the putative intracellular and transmembrane regions are common to all these splicing variants but they differ in their predicted extracellular domains. On Northern blots, the predominant form of both Tabby and EDA message is about 6 kb in size. Apparently, it corresponds to the longest and most probably full-length protein isoform (Ta-A, EDA-A) which is a 391 amino acid transmembrane protein with a collagenous domain of 19 (Gly-X-Y) repeats (with one interruption) in addition to the (Gly-X-Y) 4 repeat. A variant of Ta-A predicted to encode a 377 amino acid protein has also been described (Ferguson et al., 1997) . In addition, two other cDNAs were described in mouse: 177 amino acid and 220 amino acid polypeptides were deduced from the sequences of Tabby-B and Tabby-C, respectively . Whether they represent aberrant splicing events or code for biologically functional protein isoforms is currently unknown. In this paper, all the mouse and human protein isoforms are collectively called ectodysplasin but when necessary for clarity, they are referred to by their original, more speci®c names.
So far, very little is known about the function of the ectodysplasin protein but it has been postulated to have an important role in epithelial-mesenchymal interactions during the development of the affected epithelial appendages. The predicted structural features of the protein suggest that it may interact with membrane-associated proteins or with the extracellular matrix. Expression of EDA-O and EDA-A in the epithelial breast cancer cell line MCF-7 promote rounding up of the cells suggesting a function in adhesion or regulation of the cell cytoskeleton Baye Âs et al., 1998) . In the present study, we have analyzed the structural and functional properties of ectodysplasin, as well as its expression in the developing embryo in more detail. Two new cDNAs coding for variants of Tabby-A were isolated. In situ hybridization analysis using Tabby-A and Tabby-B speci®c probes con®rmed that Tabby-A is the major functional isoform of ectodysplasin. A thorough sequence analysis of the most C-terminal part of the ectodysplasin sequence revealed that it is a novel ligand in the TNF superfamily which consists of molecules often associated with either apoptosis or survival (Gruss and Dower, 1995) . Like the TNF ligand family members, ectodysplasin was shown to be a glycosylated, oligomeric type II membrane protein (N-terminus inside). Expression of Tabby-A in several epithelial cell lines did not seem to affect grossly the overall architecture of the cells and it did not promote cell death. Stably transfected A431 cells expressing Tabby-A were created and they were shown to have an increased adhesion to ECM.
Results

Identi®cation of two new isoforms of Tabby-A
An E17.5 embryonic mouse cDNA library was screened with a Tabby genomic probe that covered exon 1. Two clones were identi®ed. The longer one of these, E1, contained a polyA tail and was 5.0 kb long. The shorter clone, E2, was 3.1 kb long, without a polyA tail and the open reading frame was identical to that of E1 apart from a deletion of nine nucleic acids. E1 and E2 cDNAs code for 389 and 386 amino acid (aa) polypeptides, respectively. Together with the two previously published Ta-A isoforms (Ferguson et al., 1997; Srivastava et al., 1997) these clones form a group of four different Ta-A variants. We have named the different isoforms Ta-A1 ; 391 aa), Ta-A2 (E1, 389 aa), Ta-A3 (E2; 386 aa) and Ta-A4 (Ferguson et al., 1997; 377 aa) . The published Ta-A1 and Ta-A4 isoforms differ from each other by a stretch of 14 amino acids ± 295-VLVDGTYFIYSQVE-308 ± that are included in Ta-A1 but missing in Ta-A4. In both of our clones 12 of these amino acids are present with the last two residues (VE) missing. In addition, there is a difference of three amino acids between Ta-A3 and the other isoforms: DLS residues at position 265±267 are missing in Ta-A3.
Expression of Tabby
We examined Tabby expression with in situ hybridization in embryonic tissues. Both Ta-A and Ta-B speci®c probes were used in addition to an exon 1 speci®c probe which recognises all known splicing forms of Tabby. As negative controls we used corresponding sections from Tabby mice (Jackson Laboratories, JR 0314) harbouring a null allele with no detectable mRNA transcription . In general, Tabby expression levels were low requiring the use of [ 33 P] isotope and exposure times of 15 days.
Skin is one of the major organs affected in Tabby mice and EDA patients. Therefore, we ®rst analyzed skin sections from the back skin of E14±E18 mouse embryos using Ta-A speci®c probe. Expression was seen in the epidermis starting at E14 and continuing until E18 (Fig.  1A±C) . The dermis appeared to be negative but we cannot rule out the possibility of weak expression. Immature hair follicles at E15 (data not shown) were negative whereas the more differentiated follicles at E18 were positive for the Tabby signal and the expression seemed to concentrate in the hair bulb (Fig. 1C) .
In the previously published Northern blot hybridizations using whole embryos Tabby expression started at E11 (Ferguson et al., 1997; Srivastava et al., 1997) . However, in low-stringency conditions a transcript smaller (4.5 kb) than the predominant Ta-A form (6 kb) was seen at E7. We performed in situ hybridizations to E6 and E7 whole embryo sections and found Tabby, and speci®cally Ta-A, expression at these stages. In E6 embryos the signal was seen in the visceral endoderm with the exon 1 probe (Ta-A and Ta-B were not examined) (Fig. 1D) . At E7 the signal was detected in the visceral and the de®nitive endoderm with both exon 1 and Ta-A speci®c probes (Fig. 1E,F) . No Ta-B speci®c signal was detected (Fig. 1G) , nor was there any signal in E7 embryos from Tabby mice using exon 1 probe (Fig. 1H) . The signi®cance of this early expression is currently not known.
Additionally, we found Tabby expression in the developing pituitary gland and brain. At E10 Rathke's pouch, the invagination of the stromodeal roof ectoderm that differentiates into the anterior pituitary, was strongly positive with probes speci®c to both exon 1 (data not shown) and Ta-A (Fig. 1I) . The expression continued at E12 in the anterior pituitary. The posterior pituitary, which originates from an invagination of the posterior forebrain, was negative (Fig.  1J ). Ta-B probe gave negative results (data not shown). In the forebrain, bilateral patches of Tabby mRNA were seen in the neuroepithelium at E10 (Fig. 1K) . The expression continued at E12 (Fig. 1L ) and had also expanded to the lateral ventricles (data not shown). Ta-B probe detected no expression in the brain (data not shown).
Ectodysplasin is a novel member of the tumor necrosis factor (TNF) ligand superfamily
The initial protein database searches did not seem to reveal any signi®cant similarities between ectodysplasin and known gene products apart from the collagen repeats (Ferguson et al., 1997; Srivastava et al., 1997) . However, using a more careful analysis of the most C-terminal domain by the BLOCKS search program (Henikoff and Henikoff, 1994) , we noti®ed two motifs common to TNF ligand superfamily (motifs II and IV in Fig. 2A ). Multiple alignment with extracellular domains of several family members con®rmed ectodysplasin to be a novel member of the TNF superfamily ( Fig. 2A) . These proteins appear to be trimeric or multimeric type II membrane proteins although there are a few proteins which are functional also in soluble form. Ectodysplasin shows structural similarity to other TNF-like molecules especially in several regions previously described as characteristic of TNF family members (Smith et al., 1994 ) ± the highest similarity seen within regions forming b strands b, d, and i. In contrast to other protein families with notable conservation, the amino acid identities between different TNF family members are low typically ranging from 20% to 30% (Gruss and Dower, 1995) . Ectodysplasin is no exception in this respect and shows the highest identity to APRIL (26%), TRAIL (26 %), lymphotoxin-a (LT-a ) (26%), TNF-a (23%), and Fas ligand (23%) (identities obtained Fig. 1 . Embryonic expression of Tabby-A and Tabby-B. E14 (A) and E16 (B) skin epidermis is positive for Tabby-A but the hair follicles (insets) are negative. At E18 skin epidermis and hair follicles are positive (C). The expression is concentrated at the bulb of the hair follicles (inset in C). E6 embryo shows expression with exon 1 speci®c probe at the visceral endoderm (arrows) (D). Tabby exon 1 (E) and Ta-A (F) speci®c probes detect Tabby mRNA at the visceral and the de®nitive endoderm (arrows) at E7 but Ta-B probe (G) does not. Tabby E7 embryo is probed with exon 1 as a control (H). At E10, Rathke's pouch is positive with Ta-A probe (I). At E12 the anterior pituitary is positive for Ta-A (arrow) whereas the posterior pituitary is negative (arrowhead) (J). Bilateral Ta-A expression (arrows) can be seen in the E10 (K) and E12 (L) neuroepithelium.
with pairwise comparisons using the ALIGN program of Southampton Bioinformatics Data Server).
Ectodysplasin is an N-glycosylated, oligomeric type II membrane protein
When the predicted coding sequence of Ta-A2 (Fig. 2B ) was in vitro transcribed and translated, a 42±43 kDa band was synthesized (Fig. 4A , lane 1) which corresponds well to the expected size of the protein. When in vitro transcription/ translation was done in the presence of microsomal membranes, a slower migrating band appeared indicating an ER driven modi®cation of the protein (Fig. 4A, lane 2) . Identical results were obtained with Ta-A3 clone (data not shown). Ta-A2 cDNA was used in the following experiments. We have con®rmed by RT-PCR that Ta-A2 is expressed both in the developing tooth germ (E13) as well as in fresh keratinocytes derived from the skin of E18 embryos (data not shown).
Antibodies were raised in rabbits against the predicted intracellular part of Tabby (aa 1±39; anti-Tabby-N) as well as the predicted extracellular juxtamembrane region (aa 62± 168; anti-Tabby-C) (see Fig. 2B ). BHK cells were transiently transfected with a construct containing the Ta-A2 coding sequence and stained by immuno¯uorescence with the two antibodies with or without permeabilization (Fig. 3) . Antiserum against the N-terminus detected Tabby-A only in permeabilized cells (Fig. 3A,B ) whereas antibodies against aa 62±168 detected it also in non-permeabilized cells (Fig.  3D) con®rming the type II orientation of ectodysplasin. In addition to the plasmamembrane staining, a prominent ER staining was evident. When transfected cells were analyzed by Western blotting with anti-Tabby-C, a doublet band of 43/ 46 kDa was detected (Fig. 4B , lane 2). No speci®c bands were seen with the preimmune serum con®rming the speci®city of the antibody (data not shown). No endogenous protein was detected with these antibodies in any of the cell lines tested (Fig. 4B , lane 1, and data not shown, see below). Similar results were obtained with both antibodies (data not shown).
For more thorough analysis of ectodysplasin, stably transfected A431 cell lines (A431-Ta) and control cells transfected with vector only (A431-C) were produced by Geneticin selection. Only lines expressing Tabby-A at moderate or low levels were obtained. Immunoprecipitation of [ (Henikoff and Henikoff, 1994) . The b strands of TNF-a are indicated by thick lines below the alignment using the labeling de®ned previously (Smith et al., 1994) . Identical residues are in black, and conserved residues are shaded (shown when four or more family members ful®ll the criteria). Residues conserved in all seven proteins are indicated by *. (B) A schematic representation of ectodysplasin. TM, transmembrane domain; COL, collagen-like (Gly-X-Y) repeats, X, putative N-glycosylation sites. Numbers re¯ect the amino acids of Tabby-A2. membranes ( Fig. 4A ). When A431-Ta cells were metabolically labeled in the presence of tunicamycin, an inhibitor of the ®rst step in N-glycosylation, the slower migrating band disappeared indicating that Tabby-A is heterogeneously Nglycosylated (Fig. 4C , lane 5). Indeed, there are two putative N-glycosylation sites within the C-terminal domain of Tabby-A sequence.
The similarity with the TNF family members, as well as the (Gly-X-Y) 19 repeat found in Tabby-A sequence, suggested that it might be a trimeric protein. Total protein lysates of A431-Ta cells were run on a 8% SDS-PAGE under reducing and nonreducing conditions and immunoblotted (Fig. 4D ). Cells were lysed in the presence of the sulfhydryl-trapping reagent N-ethylmaleimide in order to prevent any artifactual disul®de bridge formation during or after cell lysis. Samples were mixed with Laemmli sample buffer and boiled for 3 min before loading into the gel. Similar monomeric forms were seen both in nonreduced (lane 1) and reduced samples (lane 5). It has been shown that oligomeric structures of some proteins are preserved only if electrophoresis is carried out under mild conditions (Fukunaga et al., 1990; Tanaka et al., 1995) . Indeed, when samples were only heated to 608C, a broad band corresponding to the trimeric size of Tabby-A (in addition to a faint dimeric but also slower migrating bands) were seen under nonreducing (lane 2) as well as reducing conditions (lane 4). Thus, it appears that the oligomer formation of ectodysplasin is not dependent on intermolecular disul®de bridges but is sensitive to harsh electrophoresis conditions. Similarly, the trimeric forms of some of the TNF family ligands are lost upon boiling (Tanaka et al., 1995) or detected only after chemical crosslinking (Androlewicz et al., 1992; Al-Shamkhani et al., 1997) .
The ectodomain of some of the TNF-like proteins may be shed at the plasmamembrane (Gruss and Dower, 1995) . We also looked for the possibility that ectodysplasin is cleaved at the cell surface and released into the medium (Fig. 4E ). A431-Ta cells were labeled with [ 35 S]methionine-cysteine for 7 h, the supernatant and the cell lysate was collected and immunoprecipitated with anti-Tabby-C antibody. While the cell lysate gave intensive bands (lane 2), no bands recognized by anti-Tabby-C were seen in the supernatant (lane 3), nor from transiently transfected A253 (lanes 4 and 5) or 293 cells (6 and 7), not even after prolonged exposure of the gel (data not shown). Since our antibody does not recognize the most C-terminal part of Tabby-A, samples of the labeled media were directly analyzed on SDS-PAGE but no additional bands were observed in transfected cells compared to cells transfected with the control plasmid (data not shown).
Search for ectodysplasin interacting proteins
Several lines of evidence suggest a possible interaction between ectodysplasin and epidermal growth factor (EGF) signaling pathway. Tabby phenotype can be partially rescued by injecting newborn mice with EGF (Blecher et al., 1990) . It has also been reported that the expression of EGF receptor in dermal ®broblasts of Tabby mice and EDA patients is reduced (Vargas et al., 1996) . We analyzed the localization of Tabby-A and EGFR in transiently transfected A431 cells known to express high levels of EGF receptor (Wrann and Fox, 1979) . In order to more clearly visualize a putative colocalization at plasmamembrane, only the cell surface was stained with anti-Tabby-C (and thus the typical ER staining is not seen). Ectodysplasin could be visualized on the plasmamembrane along with EGFR. However, EGFR is typically concentrated in cell± cell borders (Fig. 5A ) whereas ectodysplasin had a ®ne punctate pattern of expression all over the cell surface (Fig. 5B) . It was also evident that the level of EGFR expression did not correlate with ectodysplasin expression. Upon EGF treatment, EGFR was rapidly internalized both in transfected and nontransfected cells (Fig. 5C ). Instead, no difference was seen in the surface staining of ectodysplasin (data not shown) and it could not be detected in the internalized EGFR positive vacuoles (Fig. 5D) . We also analyzed the association of ectodysplasin with EGF receptor, as well as with E-cadherin and b -catenin often coprecipitating with EGFR (Hoschuetzky et al., 1994) , in stably transfected A431 cells by immunoprecipitation. None of these proteins could be coprecipitated with anti-Tabby-C (data not shown).
A yeast two hybrid approach was employed to attempt to ®nd novel cDNAs encoding proteins capable of binding the intracellular domain of ectodysplasin. For these experiments, the cytoplasmic tail of Tabby (amino acids 1±39) was expressed in yeast as a LexA fusion protein. Yeast were then transformed with a human keratinocyte library that expresses cDNAs fused to the acidic activation domain of B42. Then, 3:2 £ 10 6 clones were screened, 30 of them were HIS31 positive but none of them could be stained for b-galactosidase activity. Also, no speci®c ectodysplasin interacting proteins were discovered from a HeLa cell library. Ectodysplasin is able to form oligomers. Stably transfected A431-Ta total cell lysates were run under nonreducing (lanes 1 and 2) or reducing conditions (lanes 4 and 5) on 8% SDS-PAGE followed by Western blotting. The samples were either boiled (lanes 1 and 5) or heated to 608C degrees (lanes 2 and 4) for 3 min. The slower migrating band corresponding to the size of trimer is seen as long as the sample is not boiled. Lane 3 contains molecular weight markers (from top 212, 158, 116, 97.2, 66.4, 55.6, and 42.7 
Effects of ectodysplasin on cell morphology and adhesion
Expression of the human counterpart of Tabby, the EDA protein, in an epithelial breast carcinoma cell line (MCF-7) is associated with rounding up of the cells accompanied by collapse of actin ®bers Baye Âs et al., 1998) . In order to analyze whether this was a general phenomenon, Tabby-A protein was expressed in several epithelial cell lines including MCF-7, human epidermoid carcinoma lines A253 and KB, human kidney epithelial line 293, HaCat human keratinocyte cell line, and squamous carcinoma line A431 (Fig. 6 , and data not shown). Many of the Tabby transfected MCF-7 cells rounded up (data not shown), whereas no detachment was detected in any of the other cell lines studied, nor was there any prominent change in the actin cytoskeleton (Fig. 6B,D , and data not shown). Thus, it appears that Tabby-A is not causing cell rounding and it is not inducing apoptosis. This was also con®rmed by double staining of A431 cells for apoptosis and Tabby expression after 1 or 2 days of transfection (data not shown). In general, ectodysplasin expression was detected both in plasmamembrane and ER although the extent of cell surface expression varied somewhat between different cell lines. Most prominent plasmamembrane localization was seen in 293 ( Fig. 6C ) and HaCat cells (Fig. 6E) .
Cell±cell and cell±substratum interactions play a major role in epithelial organogenesis. The cell surface localization of ectodysplasin, as well as the known effect of the EDA protein in MCF-7 cells, prompted us to study its adhesive properties (Fig. 7) . The substratum adhesion characteristics of A431 cells stably transfected with Tabby-A (A431-Ta) or with the control plasmid (A431-C) were measured on plastic wells coated with Matrigel, a basement membrane preparation enriched in laminin, collagen IV, entactin, and heparan sulfate proteoglycans. The adhesion of Tabby expressing cells is shown in relation to control cells which was set at 100%. There was about 2-fold increase (202^20%) in the adhesion of ectodysplasin expressing cells as compared with the control cells. When cells were tested for attachment on ®bronectin coated wells, an increase of the similar magnitude was observed (239^42%) indicating that the stimulatory effect of Tabby on cell adhesion is not speci®c to a single ECM component.
Discussion
Expression of Tabby
Previously four different transcripts of the Tabby gene have been described (Ferguson et al., 1997; . Here we report the isolation of two novel cDNAs, Fig. 5 . Ectodysplasin has no effect on EGF receptor localization. A431 cells were transiently transfected with Tabby-A2 for 24 h followed by exposure to 50 ng/ml of EGF for 15 min (C and D), after which EGFR (A and C) and Tabby (B and D) were immunolocalized in same cells using FITC and TRITC conjugated secondary antibodies, respectively. Cells in A and B were ®rst ®xed, surface stained with anti-Tabby-C, re®xed, and permeabilized with Triton X-100 prior to staining with anti-EGFR. Cells in C and D were stained with both antibodies after permeabilization. Scale bar, 10 mm.
Ta-A2 and Ta-A3. The splicing forms can be grouped into Ta-A, Ta-B and Ta-C groups, of which Ta-A has now four different variants. All of these forms have been isolated from cDNA libraries. In this paper, all Tabby and EDA isoforms are collectively called ectodysplasin but when needed for clarity, they are referred to by their original, individual naming. Consensus splice site sequence can be seen at position 883±884 of Ta-A1 cDNA (numbering according to Srivastava et al., 1997) at the 5 H end of the region coding for the 14 amino acids missing in Ta-A4 suggesting that the difference between Ta-A1 and Ta-A4 is due to alternative splicing. The missing two amino acids of Ta-A2/Ta-A3 can be explained by the usage of again another 5 H splice site indicating that there are three alternative 5 H acceptor sites for the same intron. The difference between Ta-A3 and the other isoforms is also at the exon±intron boundary (Monreal et al., 1998) but in this case there seem to be two alternative 3 H splice sites. Isoforms corresponding to Ta-A1 and Ta-A2 have been isolated also in human and both have been identi®ed in several human cDNA libraries (Baye Âs et al., 1998) . EDA-A1 and EDA-A2 are indistinguishable by several criteria such as cellular localization and trimer formation (Sini Ezer, pers. comm.), and thus appear to be functionally equivalent. EDA patients with single amino acid mutations within the region missing from Ta-A4 have been described (Baye Âs et al., 1998; Monreal et al., 1998) indicating that Ta-A4 might not represent a functional form of ectodysplasin.
Our present in situ hybridization, Northern blotting, and RT-PCR (data not shown) analyses indicate that Tabby-B is expressed not at all, or at extremely low levels compared to Tabby-A. Expression of Tabby-C isoform was not examined but the corresponding human EDA-C protein has been shown to be unstable when expressed in 293 cells suggest- ing that this type of cDNA may be a result of aberrant RNA processing rather than a functional transcript (Sini Ezer, pers. comm.). Hence, all currently available data suggest that Tabby-A/EDA-A form, the only one containing the glycine repeats and the TNF motif, is the major functional isoform of ectodysplasin (see also below).
We found Ta-A expression in epithelial cells of the developing epidermis, hair follicle, early embryo (E6,E7), Rathke's pouch and the developing forebrain. A detailed analysis of the tooth expression will be described elsewhere (Pispa et al., in preparation). EDA is also expressed in the developing and adult brain (Montonen et al., 1998) . The signi®cance of ectodysplasin expression in the neuroectodermal locations is not known. No neuronal phenotypes have been reported in Tabby mice, but in human EDA patients mental retardation has occasionally been observed. However, these have generally been attributed to hyperthermia caused by defective sweating in early childhood. Nevertheless, thorough behavioural or hormonal analyses of EDA patients or Tabby mice have not been performed. In skin ectoderm, expression was evident already at E14 when the epithelium forms a thin uniform layer, and it persisted in the epidermis while it developed into a more complex structure. EDA has a similar expression pattern (Montonen et al., 1998) . During hair follicle development, Tabby expression could not be detected during the early budding stage whereas it was evident in the bulb region at later stages of development.
Ectodysplasin ± a novel TNF homologue
Sequence alignment with known TNF-like proteins identi®ed ectodysplasin as a novel member of the TNF superfamily which today consists of at least 15 proteins (Gruss and Dower, 1995; Wiley et al., 1995; Anderson et al., 1997; Chicheportiche et al., 1997; Hahne et al., 1998; Marsters et al., 1998; Mauri et al., 1998; Yasuda et al., 1998) . These cytokines critically regulate the immune system, in¯amma-tion, and host defence via a corresponding family of receptors which signal through induced trimerization upon binding of trimeric ligands (Gruss and Dower, 1995) . Ectodysplasin is the ®rst TNF homologue known to be required for epithelial development. Interestingly, osteoclast differentiation factor (ODF; also known as RANKL, OPGL), a crucial mediator of bone development, was recently shown to belong to the TNF ligand family (Yasuda et al., 1998; Lacey et al., 1998) . Ectodysplasin is most homologous to APRIL, a proliferation-inducing ligand with unknown receptor (Hahne et al., 1998) , especially to its last 90 amino acids (34% identity). Comparison of the mouse and human sequences shows an exceptional 100% identity within the TNF-like domain (Baye Âs et al., 1998) . Threedimensional structures of TNF-a (Eck and Sprang, 1989; Jones et al., 1989) , lymphotoxin-a (LT-a ) (Eck et al., 1992) , and CD40 ligand (Karpusas et al., 1995) have been determined. Despite relatively low level of sequence conservation they share a remarkably similar tertiary fold which consists of 10 antiparallel b -strands forming a`jellyroll' bsheet sandwich. Four of these strands (b, d, g, and i ) are involved in trimer contacts (Eck and Sprang, 1989) and represent the most conserved areas within the family members ( Fig. 2A) suggesting that all of them form similar trimeric structures. We showed that also mouse ectodysplasin exists in an oligomeric form corresponding to the size of a trimer. Furthermore, trimer formation appeared to result from noncovalent interactions between the monomers ± a feature typical to TNF family members (Jones et al., 1989; Eck et al., 1992; Tanaka et al., 1995) . It is also possible that the collagenous domain present in the ectodysplasin coding sequence contributes to trimer formation or stability (see below).
TNF superfamily proteins are synthesized as type II membrane molecules. This membrane topology was suggested for ectodysplasin already by the primary structure (Kere et al., 1996) . In addition, the shared features of TNFlike proteins include a rather short intracellular tail (ranging from 12 to 82 aa) and an N-glycosylated extracellular receptor binding moiety of about 150 aa which is preceded by a stalk or spacer region (Smith et al., 1994; Gruss and Dower, 1995) . However, in one respect ectodysplasin differs notably from the other TNF-like proteins: the juxtamembrane stalk region is considerably longer consisting of ,120 aa with no homology to known proteins and of a collagenous region of ,60 aa (Fig. 2B) . The functional importance of the collagen-like domain is suggested by the ®nding that some EDA patients have in-frame deletions that are predicted to remove two or four of the repeats (Baye Âs et al., 1998; Monreal et al., 1998) . Several secreted or type II membrane proteins with short collagen-like regions have been described many of which are involved in host defence including C1q (Sellar et al., 1991) , macrophage receptors type I and II Rohrer et al., 1990) and MARCO protein (Elomaa et al., 1995) . The C1q proteins are characterized by a globular domain situated at the C-terminus of a collagen stalk. Surprisingly, the crystal structure of the globular domain of ACRP30, a C1q family protein, revealed that it possessed a folding topology identical to TNF, although only few key residues of the TNFlike proteins are conserved in ACRP30 (Shapiro and Scherer, 1998) . Thus, the overall structure of C1q proteins and ectodysplasin appears to be very similar (Fig. 2B) . The triple helix domain of C1q is known to further multimerize to form a`bouquet' like quaternary structure. The`bouquet' formation is due to a kink in each helix which results in branching out of the helices (Reid, 1989; Brodsky and Shah, 1995) . The kink is caused by a single interruption site in the (G-X-Y) n repeat, a feature also found in ectodysplasin sequence. Currently it is not known whether ectodysplasin is able to form such multimeric superstructures but they would provide a very ef®cient means for signaling through high-valency receptor clustering.
Members of the TNF ligand superfamily act either locally through direct cell-to-cell contact or as secreted proteins produced by proteolytic shedding (Gruss and Dower, 1995) . We did not ®nd any evidence for proteolytical cleavage of ectodysplasin in the three cell lines tested. It is, however, possible that these cells do not possess the proteinase required for cleavage. On the other hand, the ectodomains of TNF-a , LT-a, and TWEAK are shed in 293 cells (Chicheportiche et al., 1997) , one of the cell lines analyzed in our study, but it is not clear whether all TNF-like proteins are cleaved by the same disintegrin metalloproteinase as TNF-a (Moss et al., 1997) . Two lines of recent evidence strongly support the conclusion that ectodysplasin is a member of the TNF superfamily. Firstly, the importance of the TNF-like region for ectodysplasin function is emphasized by the ®ndings that about half of the missense mutations found in EDA patients so far are within the TNF domain and mostly within the conserved regions (Kere et al., 1996; Baye Âs et al., 1998; Monreal et al., 1998) . Two of the mutations, namely H252L and G299S, change residues absolutely conserved within TNF family members ( Fig. 2A) . In the homologous proteins equivalent residues participate in forming the protomer's hydrophobic core required for trimer contacts (Eck and Sprang, 1989; Jones et al., 1989; Eck et al., 1992; Karpusas et al., 1995) . Secondly, a recent report (Headon and Overbeek, 1999) described the cloning of the mouse gene defective in downless, one of the two mouse mutants with phenotypes identical to Tabby. The deduced protein sequence revealed it to be a novel TNF receptor homologue making it a very likely candidate for ectodysplasin receptor. In skin the site of action of downless gene has been localized to the epidermis by means of dermal±epidermal recombination grafting (Sofaer, 1973) , which together with our results, suggest juxtacrine mode of signaling. However, de®nitive conclusions must await for results on protein localization of both the ligand and the receptor as well as direct biochemical proof.
Functions of ectodysplasin
Already some time ago it was proposed that ectodysplasin and EGF in¯uence the same biochemical pathway. The effect of EGF is opposite to that of the Ta mutation, and EGF can rescue dermal ridge and sweat gland morphogenesis in newborn Ta mice (Blecher et al., 1990) . Suggestively, the expression of Tabby and EGF receptor overlap in the developing tooth (Partanen and Thesleff, 1987; Srivastava et al., 1997) . We did not observe any direct interaction between EGFR and ectodysplasin in cultured cells nor could we see any correlation between EGFR and ectodysplasin expression levels. Of course, these results do not exclude the possibility that they affect the same signaling pathway or same phenomenon such as proliferation through convergent pathways. Many of the TNF-like proteins promote proliferation and EGF is known to induce proliferation and differentiation of epidermis and other epithelial tissues. However, EGF receptor knockout mice do not have a tooth phenotype although the development of many other tissues also affected in Ta mice and EDA patients in impaired (Miettinen et al., 1995) . The typical feature of the molars of Ta mice ± smaller size and reduced number of cusps ± could not be rescued in organ culture by application of EGF (Pispa et al., unpublished results) . Clearly, further studies are required to clarify the possible connection between ectodysplasin and EGF signaling pathway.
In this report, we have shown that expression of ectodysplasin in A431 cells promotes cell attachment to substratum in a manner independent on the ECM components used. These results appear to be contradictory to the ones obtained with EDA transfected MCF-7 cells which have a rounded, detached appearance Baye Âs et al., 1998 ). We did not detect similar morphology in any other epithelial cell line tested suggesting that there may be an interesting difference in the ectodysplasin interacting molecules between MCF-7 and the other cell lines. In principle, there are several possible explanations for the effects of ectodysplasin on adhesion. Firstly, it could be caused by direct interaction between ectodysplasin and ECM components, e.g. through the collagenous domain as postulated for the type XVII collagen, a component of hemidesmosomes, which contains a series of collagen-like repeats (Aumailley and Gayraud, 1998) . Also, macrophage scavenger receptors have been implicated in cell±matrix interactions (Fraser et al., 1993) , and the expression of type I seems to promote adhesion even on tissue culture grade plastic (Robbins and Horlick, 1998) . Secondly, ectodysplasin could modulate the af®nity of adhesion receptors such as integrins which are known to be subject to multiple levels of regulation (Gumbiner, 1996) . According to these two possibilities ectodysplasin could be a molecule with multiple functions executed by different protein domains. Thirdly, the adhesive phenotype could be an indirect result due to signaling via the cognate receptor. Cell±matrix interactions at the epithelial± mesenchymal interface are central regulators of the morphogenesis of a variety of organs including the tooth, hair, and glands affected in Ta mouse and EDA patients (Gumbiner, 1996) . The expression of Tabby in epithelial cells facing the basement membrane during early tooth and skin development is in line with such functions of ectodysplasin Pispa et al., unpublished results) .
Two major responses triggered by various TNF-like ligands are induction of apoptosis or cell survival, and the activation of a heterodimeric transcription factor, nuclear factor k B (NF-k B). Recent evidence suggests that NF-k B largely controls the anti-apoptotic response (Baichwal and Baeuerle, 1997) . Interestingly, NF-k B was recently shown to be required for normal limb development and to transmit growth factor signals between the epithelium and the mesenchyme (Bushdid et al., 1998; Kanegae et al., 1998) . Our evidence suggests that ectodysplasin is not inducing cell death. Even MCF-7 cells which rounded up upon EDA expression were non-apoptotic .
However, more conclusive evidence for the role of ectodysplasin in regulation of cell survival, as well as other cellular functions, will be accessible only when large enough amounts of puri®ed soluble ectodomain is available, and its effects can be tested in cell and organ cultures without the limitation of variable ef®ciencies of transient transfections.
In conclusion, this paper shows that the ectodysplasin protein, encoded by the mouse Tabby and human EDA genes, is a novel TNF homologue with many biochemical characteristics typical to TNF superfamily ligands. In addition, ectodysplasin was shown to promote adhesion of epithelial cells to extracellular matrix, a function consistent with its postulated role in epithelial±mesenchymal interactions during embryonic organ development. Ectodysplasin together with the recently identi®ed osteoclast differentiation factor are examples of novel TNF family members which are involved in developmental processes outside the immune system. The widespread expression patterns of two other TNF-like proteins, TWEAK and TRAIL, indicate that there may be still more functional variety to be uncovered in this family (Chicheportiche et al., 1997; Wiley et al., 1995) . Ectodysplasin may also have redundant so far unidenti®ed homologues since it is expressed in a variety of tissues not affected in Tabby mice or EDA patients. All evidence suggests that Tabby and EDA are true loss-of-function mutations. However, the phenotype is variable both in mice and human suggesting that ectodysplasin signaling is in¯uenced by genetic background. In the future, it will be interesting to see how ectodysplasin is associated with other signaling pathways regulating epithelial morphogenesis.
Experimental procedures
Animals
Wild type mouse embryos were from a CBAT6T6 £ NMRI cross. The Tabby mice used, B6CBACa-A w-J /A-Ta, were obtained from Jackson Laboratories, Bar Harbor, Maine, USA (stock #JR 0314) and were kept by breeding Ta/0 females to Ta/Y males. All embryos from the cross were either Ta/0 or Ta/Ta females or Ta/Y males and displayed the Tabby phenotype.
Cloning of Tabby-A isoforms
An E17.5 mouse embryo cDNA library (Clontech) was screened in high stringency conditions using as probe a 1.5 kb XbaI±EcoRI Tabby genomic fragment containing exon 1 . The two positive clones E1 (5.0 kb) and E2 (3.1 kb) were subcloned into pGEM5Z (Promega) and sequenced. Sequencing was performed with an Automated Pharmacia LKB A.L.F. DNA Sequencer. Sequence assembly was done using the xGAP program on a Sun workstation (Bon®eld et al., 1995) . E1 and E2 have the EMBL database accesion numbers AJ243657 and AJ243658, respectively.
In situ hybridization
In situ hybridizations were done as previously described Srivastava et al., 1997) . Tabby-A speci®c probe was derived form Tabby-A3 clone and corresponds to nucleotides 2371±3164 and recognizes all Tabby-A forms, and Tabby-B speci®c probe corresponds to nucleotides 814±1620 of Tabby-B (GenBank accession number AF016639). The images were digitized with ImagePro and NIH Image 1.60 software and further manipulated with Adobe Photoshop and Micrografx Designer software.
In vitro transcription and translation
For in vitro transcription of Tabby cDNA, an NcoI and SphI cleaved fragment of the original cDNA clone E1 was cloned into pGEM3 (Promega)-derived pHOS1 vector. The resulting plasmid pHOS1-Ta was cleaved with HindIII and transcribed with T7 RNA polymerase as speci®ed by the manufacturer (Promega). The transcripts were used for in vitro translation in the presence of [ 35 S]methionine-cysteine (Promix, Amersham) in a rabbit reticulocyte system in the absence or presence of microsomal membranes (Promega).
Production of antibodies
For the production of antibodies against the predicted intracellular part of Tabby (anti-Tabby-N) the sequence coding for amino acids 1 to 39 was PCR ampli®ed with primers creating an NcoI recognition site at the 5 H end and a translation termination codon and a HindIII site at the 3 H end. The PCR product was cleaved with NcoI and HindIII and cloned into a bacterial expression vector pTAT (Pera È-nen et al., 1996; Johan Pera Ènen, unpublished results) which codes for a his-tagged thioredoxin protein followed by a multiple linker site. The resulting fusion product was expressed in JM109(DE3) cells (Promega) after induction for 3 h with 250 mM isopropyl-b -d-thio galactopyranoside (IPTG). The fusion protein was puri®ed by TALON metal af®nity chromatography (Clontech) as recommended. Antibodies against the predicted extracellular part of Tabby were produced in a corresponding way using a his-tagged thioredoxin fused to the amino acids 62±168 of Tabby-A as antigen (anti-Tabby-C). Two rabbits were immunized with both of the antigens. For af®nity puri®cation of the antisera, the same Tabby sequences were fused to a his-tagged glutathione S-transferase (GST) in pGAT-2 vector (Johan Pera Ènen, unpublished results) and expressed in bacteria and puri®ed as the antigens described above. The antisera were af®nity puri®ed by absorption to puri®ed his-tagged GST fusion proteins immobilized in the HiTrap NHS-activated column (Pharmacia). Antisera were diluted with 20 mM sodium phosphate pH 7.2, applied to the column, washed with 20 mM sodium phosphate, 200 mM NaCl, and eluted with 20 mM glycine pH2.3, 150 mM NaCl followed by immediate neutralization with Na 2 HPO 4 .
Cell culture and transfection
BHK cells were cultivated in MEM supplemented with 7.5% fetal calf serum, 5% tryptose broth, 2 mM glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin. A431, HaCat, and 293 cells were propagated in DMEM supplemented with 10% fetal calf serum, 2 mM glutamine, and penicillin/streptomycin, and A253, MCF-7, and KB cells in MEM with the same supplements. For eukaryotic expression of Tabby-A, the coding sequence was cloned into pCIneo vector (Promega) to obtain pCI-neo-Ta. For transfection, cells were plated on 60 mm plates or on glass coverslips on 35 mm plates one day prior to transfection. BHK and KB cells were transfected by lipofection with the Lipofectin kit (Bethesda Research Laboratories Inc.), and 293, A253, A431, HaCat, and MCF-7 cells with the Fugenee6 reagent (Boehringer Mannheim) following the instructions of the manufacturers. After 24 h, the transfected cells were prepared for immuno¯uorescence, or labeled with [ 35 S]methionine-cysteine (.1000 Ci/mmol, Promix, Amersham) at 200 mCi per ml for various times. For the experiments employing the N-glycosylation inhibitor, cells were preincubated with 5 mg/ml tunicamycin for 3 h followed by a 4 h labeling in the presence of the inhibitor. For the treatment with EGF, transfected A431 cells were incubated in serum-free MEM supplemented with 0.2% BSA and 20 mM Hepes pH7.2 for 2 h followed by treatment with 50 ng/ml EGF (Boehringer Mannheim) for 15 min. For the production of stably transfected cell lines, A431 cells were transfected with pCI-neo (A431-C) or pCIneo-Ta (A431-Ta) for 48 h. The cells were then subjected to drug selection in culture medium containing Geneticin (Boehringer Mannheim) at 1000 mg/ml. Single colonies were cloned and expanded in selection medium.
Indirect immuno¯uorescence
Transfected cells were ®xed with 3% paraformaldehyde and free aldehyde groups were quenched by 20 mM NH 4 Cl. When indicated, cells were permeabilized with 0.05% Triton X-100 and stained with af®nity puri®ed anti-Tabby antibodies or with monoclonal anti-EGF antibody (Murthy et al., 1987) . Oregon green 488 -phalloidin (Molecular Probes) was used to stain F-actin. Donkey anti-rabbit immunoglobulin G conjugated to tetramethylrhodamine (TRITC), or uorescein (FITC)-conjugated goat anti-mouse IgG (Jackson ImmunoResearch Laboratories) were used as secondary antibodies.
Immunoprecipitation, SDS-PAGE and Western blotting
For immunoprecipitation, transfected cells were washed with PBS and extracted on ice with 1% NonidetP-40, 400 mM NaCl, 50 mM Tris±HCl pH 8.0, 2 mM EDTA, 0.02% NaN 3 ,1 mM Pefabloc w SC (Boehringer Mannheim), and 100 U/ml aprotinin (Boehringer Mannheim) (NET buffer) with 0.25% sodium deoxycholate. Lysates were collected and cell debris removed by centrifugation at 10 000 £ g for 10 min at 148C. Aliquots of cell lysates were immunoprecipitated in NET buffer with af®nity-puri®ed anti-Tabby antibodies. After overnight incubation at 148C precipitates were collected with 40 ml of protein-A-agarose (Boehringer Mannheim). In coprecipitation experiments, 150 mM NaCl was used throughout the procedure. Protein samples were analyzed by SDS-PAGE in 8%, 10%, or 12% gels. For uorography, gels were soaked in 1 M salicylic acid for 30 min, dried, and exposed to autoradiography ®lm. For immunoblotting, proteins were transferred onto a Hybond-C-extra membrane (Amersham) and blots were developed using enhanced chemiluminesence (ECL, Amersham). Af®-nity puri®ed antibodies recognizing Tabby, EGFR (Sigma), E-cadherin (Transduction Laboratories), or b -catenin (Transduction Laboratories) were used as primary antibodies, and swine anti-rabbit antibody (DAKO) or goat antimouse antibody (Sigma) conjugated to horseradish peroxidase were used as secondary antibodies.
Cell-matrix adhesion assay
The adhesion of cells to extracellular matrix components was done essentially as previously described (Xu et al., 1998) . Brie¯y, 96-well plates were coated with Matrigel (Collaborative Biomedical) via absorption from buffered solution at 1.5 mg/ml for 2 h followed by blockage with 2% bovine serum albumin (BSA) in PBS for 2 h at room temperature (or only coated with BSA) and rinsed with PBS. Fibronectin was used for coating at 200 mg/ml overnight at 148C and nonspeci®c cell adhesion was blocked similarly with BSA. Subcon¯uent A431-C and A431-Ta cells were rinsed with PBS and detached by trypsin/EDTA. Harvested cells were washed once with serum-free DMEM containing 20 mg/ml trypsin inhibitor and resuspended in serum-free DMEM at equal densities. 100 ml of cells (6 £ 10 5 cells/ml) were added to each well and allowed to attach. After 60 min, unattached cells were removed by gently washing three times with PBS and adherent cells were ®xed with 10% formalin for 30 min followed by staining with 1% Toluidine Blue for 60 min. Wells were washed extensively with water and air dried. The dye was eluted in 2% SDS and the absorbance was measured at OD 620 on microtiter plate reader. Nonspeci®c staining of coated wells (without added cells) was also measured and subtracted from each value. Nonspeci®c attachment of cells on wells coated with BSA alone was negligible.
Yeast two-hybrid analysis
The intracellular part of Tabby was cloned into a LexA bait plasmid pEG202 (Gyuris et al., 1993) resulting in a Cterminal LexA fusion protein. The N-terminal part of Tabby cDNA (amino acids 1-39) was PCR ampli®ed with primers creating an EcoRI site at the 5 H end and a stop codon and a HindIII site at the 3 H end. Five additional glycines were created at the junction region in order to permit¯exibility in the folding of the individual domains of the fusion product. The two-hybrid analysis was done essentially as described (Gyuris et al., 1993) using either a human primary keratinocyte library KER1 (a generous gift of Antonis Zervos) or a HeLa cell library (Gyuris et al., 1993) as prey. Protein kinase Ck1 bait was used as a positive control and gave the expected results.
